MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
Juan J. Alburquerque-Béjar(Josep Carreras Leukaemia Research Institute), Montse Sánchez‐Céspedes(Josep Carreras Leukaemia Research Institute)
Cited by 34
Related Papers
A gene-alteration profile of human lung cancer cell lines
|Human Mutation|2009|144
Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors
|Human Mutation|2010|81
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
|Nature Communications|2021|59